Icahn pushes harder to stop Mylan #39;s King acquisition PITTSBURGH Carl Icahn, the largest shareholder of Mylan Laboratories, is now threatening to push for new company directors to stop the generic drug maker #39;s four (B) billion-dollar takeover bid of King Pharmaceuticals.